Serial 90068900
Live / Registered — Registered (as of 13 Feb 2024)
What this means for you
Registered since 13 Feb 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90068900
- Registration number
- 7304980
- Mark type
- Design / logo
- Filed
- 23 Jul 2020
- Published for opposition
- 10 Nov 2020
- Registered
- 13 Feb 2024
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, menopausal, metabolic, musculoskeletal, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, and stroke; Pharmaceutical preparations, namely, anti-infective preparations and medicated dermatological preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Feb 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 13 Feb 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Jan 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Jan 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Dec 2023 — USE AMENDMENT FILED
- 15 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 20 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jun 2023 — SOU EXTENSION 5 GRANTED
- 09 Jun 2023 — SOU EXTENSION 5 FILED
- 17 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2023 — SOU TEAS EXTENSION RECEIVED